CAS 910463-68-2

Semaglutida

Descrição:

Semaglutida é um análogo sintético do peptídeo-1 semelhante ao glucagon (GLP-1), utilizado principalmente no manejo do diabetes tipo 2 e da obesidade. É caracterizado por sua capacidade de aumentar a secreção de insulina em resposta a níveis elevados de glicose no sangue, ajudando assim no controle glicêmico. Semaglutida tem uma longa meia-vida devido à sua resistência à degradação enzimática, o que permite a administração subcutânea uma vez por semana. A substância é tipicamente administrada como uma solução para injeção e é conhecida por sua eficácia em promover a perda de peso além de seus efeitos redutores de glicose. Seu mecanismo de ação envolve estimular a liberação de insulina, inibir a secreção de glucagon e retardar o esvaziamento gástrico, o que contribui coletivamente para melhorar os resultados metabólicos. Semaglutida também está associado a um perfil de segurança favorável, embora possa ter efeitos colaterais, como distúrbios gastrointestinais. Como um medicamento peptídico, é composto por 31 aminoácidos e tem um peso molecular que reflete sua estrutura complexa. No geral, Semaglutida representa um avanço significativo nas opções de tratamento para diabetes e obesidade.

Sinónimos:

• Sermaglutide

Semaglutide

CAS: 910463-68-2

Acylated GLP-1 analog with a half-life of 160 h. Semaglutide is under evaluation for the management of diabetes II. Due to its prolonged half-life, the peptide has to be injected only once per week. Bachem provides this product solely for uses within the scope of any statute or law providing for an immunity, exemption, or exception to patent infringement (“Exempted Uses”), including but not limited to 35 U.S.C. § 271(e)(1) in the United States, the Bolar type exemption in Europe, and any corresponding exception to patent infringement in any other country. It is the sole responsibility of the purchaser or user of this product, and the purchaser or user of this product agrees to engage only in such Exempted Uses, and to comply with all applicable intellectual property laws and/or regulations. The purchaser of this product agrees to indemnify Bachem against all claims in connection with the performance of the respective commercial agreement (e.g. supply agreement) and possible infringements of intellectual property rights.

Fórmula: C₁₈₇H₂₉₁N₄₅O₅₉

Pureza: 97.5%

Cor e Forma: White

Peso molecular: 4113.64

Ref: 01-4091661

Semaglutide

CAS: 910463-68-2

Fórmula: C₁₈₇H₂₉₁N₄₅O₅₉

Pureza: 99%

Cor e Forma: Solid

Peso molecular: 4113.5775

Ref: IN-DA00H230

Semaglutide-d8 Tetratrifluoroacetate

CAS: 910463-68-2

Fórmula: C₁₈₇H₂₈₃D₈N₄₅O₅₉·4C₂HF₃O₂

Cor e Forma: White To Off-White Solid

Peso molecular: 4121.69 4*114.02

Ref: 4Z-PS-189003

Semaglutide

CAS: 910463-68-2

Fórmula: C₁₈₇H₂₉₁N₄₅O₅₉

Cor e Forma: White To Off-White Solid

Peso molecular: 4113.64

Ref: 4Z-PS-189002

Semaglutide-d15 Tetratrifluoroacetate

CAS: 910463-68-2

Fórmula: C₁₈₇H₂₇₆D₁₅N₄₅O₅₉·4C₂HF₃O₂

Peso molecular: 4128.73 4*114.02

Ref: 4Z-PS-189004

Semaglutide-d8

CAS: 910463-68-2

Fórmula: C₁₈₇H₂₈₃D₈N₄₅O₅₉

Peso molecular: 4121.69

Ref: 4Z-PS-189038

Semaglutide-13C16,15N4

CAS: 910463-68-2

Fórmula: C₁₇₁₁C₁₆H₂₉₁N₄₁₁₅N₄O₅₉

Peso molecular: 4133.49

Ref: 4Z-PS-189050

Semaglutide

CAS: 910463-68-2

Semaglutide is a glucagon-like peptide 1 receptor (GLP-1R) agonist(EC50 of 6.2 pM in a reporter assay using BHK cells expressing the human receptor).

Fórmula: C₁₈₇H₂₉₁N₄₅O₅₉

Pureza: 96.92% - 99.78%

Cor e Forma: White Solid

Peso molecular: 4114

Ref: TM-T19850

Semaglutide

CAS: 910463-68-2

Pureza: ≥ 98.0%

Cor e Forma: White powder

Ref: 7W-GW8695

Semaglutide . AcOH

CAS: 910463-68-2

Pureza: ≥ 98.0%

Cor e Forma: Solid lyophilized powder

Ref: 7W-GW1848

Semaglutide

CAS: 910463-68-2

Fórmula: C₁₈₇H₂₉₁N₄₅O₅₉

Peso molecular: 4113.64

Ref: ST-EA-CP-S78000

Semaglutide sodium

CAS: 910463-68-2

Cymit Quimica provides this product solely for uses within the scope of any statute or law providing for an immunity, exemption, or exception to patent infringement (“Exempted Uses”), including but not limited to 35 U.S.C. § 271(e)(1) in the United States, the Bolar type exemption in Europe, and any corresponding exception to patent infringement in any other country. It is the sole responsibility of the purchaser or user of this product, and the purchaser or user of this product agrees to engage only in such Exempted Uses, and to comply with all applicable intellectual property laws and/or regulations. The purchaser of this product agrees to indemnify Cymit Quimica against all claims in connection with the performance of the respective commercial agreement (e.g. supply agreement) and possible infringements of intellectual property rights.

Fórmula: C₁₈₇H₂₉₁N₄₅O₅₉•Nax

Pureza: Min. 98.0 Area-%

Cor e Forma: Powder

Peso molecular: 4,113.58 g/mol

Ref: 3D-BS182652

Semaglutide

CAS: 910463-68-2

Anti-diabetic and anti-obesity drug.  We also have the heavy labelled material, CRB1301886. Cymit Quimica provides this product solely for uses within the scope of any statute or law providing for an immunity, exemption, or exception to patent infringement (“Exempted Uses”), including but not limited to 35 U.S.C. § 271(e)(1) in the United States, the Bolar type exemption in Europe, and any corresponding exception to patent infringement in any other country. It is the sole responsibility of the purchaser or user of this product, and the purchaser or user of this product agrees to engage only in such Exempted Uses, and to comply with all applicable intellectual property laws and/or regulations. The purchaser of this product agrees to indemnify Cymit Quimica against all claims in connection with the performance of the respective commercial agreement (e.g. supply agreement) and possible infringements of intellectual property rights.

Fórmula: C₁₈₇H₂₉₁N₄₅O₅₉

Pureza: Min. 99.0 Area-%

Cor e Forma: Powder

Peso molecular: 4,113.58 g/mol

Ref: 3D-FS171058

Semaglutide

CAS: 910463-68-2

Ref: BE-RMCP512000